⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5536490 | 0.83 | — | — | |
| SCHEMBL9287686 | 0.79 | — | — | |
| SCHEMBL19833264 | 0.76 | CHRNB2 (0.33) | — | |
| SCHEMBL14557534 | 0.72 | — | — | |
| SCHEMBL17450515 | 0.70 | MAPT (0.36) | — | |
| SCHEMBL868382 | 0.69 | — | — | |
| SCHEMBL14557552 | 0.68 | KDM4E (0.50) | — | |
| SCHEMBL14557533 | 0.68 | — | — | |
| SCHEMBL14557536 | 0.68 | — | — | |
| SCHEMBL18722155 | 0.68 | EPHX1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220186274-A1 | POLYNUCLEOTIDE MODIFICATION METHODS | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2022-06-16 | — | — | US | claimed |
| US-11186857-B2 | Polynucleotide modification methods | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2021-11-30 | — | — | US | claimed |
| US-20200131549-A1 | POLYNUCLEOTIDE MODIFICATION METHODS | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2020-04-30 | — | — | US | claimed |
| EP-3033435-B1 | METHOD FOR FRAGMENTING NUCLEIC ACID BY MEANS OF TRANSPOSASE | OXFORD NANOPORE TECH LTD (GB) | 2019-07-24 | — | — | EP | claimed |
| EP-3033435-A1 | METHOD | Oxford Nanopore Technologies Limited (GB) | 2016-06-22 | — | — | EP | claimed |
| WO-2015022544-A1 | METHOD | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-02-19 | — | — | WO | claimed |
| US-7531306-B2 | Nucleic acid hybridization methods | GENEOHM SCIENCES, INC. (US) | 2009-05-12 | — | — | US | claimed |
| EP-1689879-A4 | NUCLEIC ACID HYBRIDIZATION METHODS | GENEOHM SCIENCES INC (US) | 2008-08-27 | — | — | EP | claimed |
| EP-1689879-A2 | NUCLEIC ACID HYBRIDIZATION METHODS | Geneohm Sciences, Inc. (US) | 2006-08-16 | — | — | EP | claimed |
| US-20050176035-A1 | Destabilization of hybridization via DNA N-glycosylase/uridine nucleosidase, insertion of probe; kits | GENEOHM SCIENCE, INC. | 2005-08-11 | — | — | US | claimed |
| WO-2005049848-A2 | NUCLEIC ACID HYBRIDIZATION METHODS | GENEOHM SCIENCES, INC. (US) | 2005-06-02 | — | — | WO | claimed |
| US-12024541-B2 | Transmembrane pore consisting of two CsgG pores | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-07-02 | — | — | US | disclosed |
| US-12018326-B2 | Mutant pore | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-06-25 | — | — | US | disclosed |
| CN-111534504-B | Method of ligating one or more polynucleotide binding proteins to a target polynucleotide | 牛津纳米孔科技公开有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-20240117421-A9 | MUTANT PORES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-04-11 | — | — | US | disclosed |
| WO-2007095923-A1 | METHOD FOR ANALYSING MULTIPLEX-MIXTURES COMPRISING NUCLEIC ACID AMPLIFICATION PRODUCTS HAVING OVERLAPPING DETECTION AREAS | BIOTYPE AG (DE) | 2007-08-30 | — | — | WO | disclosed |
| EP-1689879-A2 | NUCLEIC ACID HYBRIDIZATION METHODS | Geneohm Sciences, Inc. (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2006084132-A2 | REAGENTS, METHODS, AND LIBRARIES FOR BEAD-BASED SQUENCING | AGENCOURT BIOSCIENCE CORP. (US) | 2006-08-10 | — | — | WO | disclosed |
| US-20050176035-A1 | Destabilization of hybridization via DNA N-glycosylase/uridine nucleosidase, insertion of probe; kits | GENEOHM SCIENCE, INC. | 2005-08-11 | — | — | US | disclosed |
| WO-2005049848-A2 | NUCLEIC ACID HYBRIDIZATION METHODS | GENEOHM SCIENCES, INC. (US) | 2005-06-02 | — | — | WO | disclosed |